| CIM11 |
LD50.02 |
Karyotype 46, X with abnormal sex chromosome, except iso Xq
|
|
| CIM11 |
LD50.03 |
Mosaicism, 45, X, 46, XX or XY
|
|
| CIM11 |
LD50.04 |
Mosaicism, 45, X or other cell line with abnormal sex chromosome
|
|
| CIM11 |
LD50.1 |
Karyotype 47,XXX
|
|
| CIM11 |
LD50.2 |
Mosaicism, lines with various numbers of X chromosomes
|
|
| CIM11 |
LD50.3 |
Klinefelter syndrome
|
|
| CIM11 |
LD50.30 |
Klinefelter syndrome with karyotype 47,XXY, regular
|
|
| CIM11 |
LD50.31 |
Klinefelter syndrome, male with more than two X chromosomes
|
|
| CIM11 |
LD51 |
Structural anomalies of chromosome X, excluding Turner syndrome
|
|
| CIM11 |
LD52 |
Number anomalies of chromosome Y
|
|
| CIM11 |
LD52.0 |
Male with 46,XX karyotype
|
|
| CIM11 |
LD52.1 |
Male with double or multiple Y
|
|
| CIM11 |
LD53 |
Structural anomalies of chromosome Y
|
|
| CIM11 |
LD54 |
Male with sex chromosome mosaicism
|
|
| CIM11 |
LD55 |
Fragile X chromosome
|
|
| CIM11 |
LD56 |
Chimaera 46, XX, 46, XY
|
|
| CIM11 |
LD56.0 |
Androgenetic chimaera
|
|
| CIM11 |
LD56.1 |
Gynogenetic chimaera
|
|
| CIM11 |
LD90 |
Conditions with disorders of intellectual development as a relevant clinical feature
|
|
| CIM11 |
LD90.0 |
Angelman syndrome
|
|
| CIM11 |
LD90.1 |
Early-onset parkinsonism - intellectual deficit
|
|
| CIM11 |
LD90.2 |
Pelizaeus-Merzbacher-like disease
|
|
| CIM11 |
LD90.3 |
Prader-Willi syndrome
|
|
| CIM11 |
LD90.4 |
Rett syndrome
|
|
| CIM11 |
MA00 |
Symptom or complaint of the blood
|
|
| CIM11 |
MA01 |
Enlarged lymph nodes
|
|
| CIM11 |
MA01.0 |
Localised lymph node enlargement
|
|
| CIM11 |
MA01.1 |
Generalised lymph node enlargement
|
|
| CIM11 |
MA10 |
Abnormal serum enzyme levels
|
|
| CIM11 |
MA10.0 |
Elevation of levels of transaminase or lactic acid dehydrogenase
|
|
| CIM11 |
MA10.1 |
Abnormal levels of other specified serum enzymes
|
|
| CIM11 |
MA10.2 |
Abnormal level of unspecified serum enzyme
|
|
| CIM11 |
MA11 |
Clinical findings of hormones in blood, blood-forming organs, or the immune system
|
|
| CIM11 |
MA12 |
Clinical findings of drugs, medicaments or biological substances in blood, blood-forming organs, or the immune system
|
|
| CIM11 |
MA12.0 |
Finding of opiate drug in blood
|
|
| CIM11 |
MA12.1 |
Finding of cocaine in blood
|
|
| CIM11 |
MA12.2 |
Finding of hallucinogen in blood
|
|
| CIM11 |
MA12.3 |
Finding of psychotropic drug in blood
|
|
| CIM11 |
MA12.4 |
Finding of steroid agent in blood
|
|
| CIM11 |
MA13 |
Clinical findings of substances chiefly nonmedicinal as to source in blood, blood-forming organs, or the immune system
|
|
| CIM11 |
MA13.0 |
Finding of abnormal level of heavy metals in blood
|
|
| CIM11 |
MA13.00 |
Abnormal level of lead in blood
|
|
| CIM11 |
MA13.1 |
Finding of alcohol in blood
|
|
| CIM11 |
MA14 |
Immunological findings in blood, blood-forming organs, or the immune system
|
|
| CIM11 |
MA14.0 |
Laboratory evidence of human immunodeficiency virus
|
|
| CIM11 |
MA14.1 |
Certain specified immunological findings
|
|
| CIM11 |
MA14.10 |
Abnormal reaction to tuberculin test
|
|
| CIM11 |
MA14.11 |
Anticitrullinated protein antibody negative
|
|
| CIM11 |
MA14.12 |
Anticitrullinated protein antibody positive
|
|
| CIM11 |
MA14.13 |
Anti-nuclear antibody negative
|
|